← Back to Clinical Trials
Recruiting NCT06736522

NCT06736522 Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06736522
Status Recruiting
Phase
Sponsor Boston University Charles River Campus
Condition Adolescent Behavior Problem
Study Type INTERVENTIONAL
Enrollment 504 participants
Start Date 2024-12-16
Primary Completion 2028-03

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Leadership, Engagement, and youth Action Program with MindfulnessEnvisionIT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 504 participants in total. It began in 2024-12-16 with a primary completion date of 2028-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current study tests the feasibility and effectiveness of a youth intervention designed to provide meaningful leadership opportunities through the acquisition of leadership skills as well as mindfulness practice, LEAP: Leadership, Engagement, and youth Action Program with Mindfulness. The goal of this project is to determine whether the Leadership, Engagement, and youth Action Program with Mindfulness (LEAP) curriculum, which was developed with youth, is a feasible and effective intervention for fostering leadership and well-being. The investigators seek to understand whether LEAP can support wellbeing for youth as a strategy to increase youth mental, emotional, and behavioral (MEB) health.

Eligibility Criteria

Inclusion Criteria: * Adolescents ages 14 and older in grades 9-12 during the Fall/Winter or in grades 9-11 during the Spring * Enrolled in a partner site in Massachusetts or Illinois * Adolescents are only included with parent consent and youth assent if they are under the age of 18. Adolescents at least 18 years old can provide consent. Exclusion Criteria: * They participated in the pilot phase (UG3) * They cannot commit to participation in the full study (e.g., attendance at all intervention sessions) * They are not in grades 9-12 at a partner site * Parent/guardian has a preferred consent language other than English or Spanish.

Contact & Investigator

Central Contact

Jennifer Greif Green, PhD

✉ jggreen@bu.edu

📞 617-353-3253

Principal Investigator

Mario Cruz-Gonzalez, PhD

PRINCIPAL INVESTIGATOR

Massachusetts General Hospital

Frequently Asked Questions

Who can join the NCT06736522 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, studying Adolescent Behavior Problem. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06736522 currently recruiting?

Yes, NCT06736522 is actively recruiting participants. Contact the research team at jggreen@bu.edu for enrollment information.

Where is the NCT06736522 trial being conducted?

This trial is being conducted at Chicago, United States, Boston, United States, Boston, United States.

Who is sponsoring the NCT06736522 clinical trial?

NCT06736522 is sponsored by Boston University Charles River Campus. The principal investigator is Mario Cruz-Gonzalez, PhD at Massachusetts General Hospital. The trial plans to enroll 504 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology